Comment: Interpretation of drug mutagenicity tests
B. Priestly
DOI: https://doi.org/10.5694/j.1326-5377.1984.tb113065.x
1984-08-01
Abstract:l HagenTB, Bergan T, Liavag I. Prophylactic metronidazole in elective colorectal surgery. Acta ChirScand 1980; 146: 71·75. 4. PereraM, Chipping PM, NooneP. Intravenous metronidazole in the treatmentof prophylaxis of anaerobic infection. J Antimicrob Chemother 1980; 6: 105·112. 5. CocksPS, Munro R, Norton B,et al. Prospective comparative trialof tinidazole and metronidazole as prophylaxis for elective hysterectomy. Aust NZ J Obstet Gynaeco/1981; 21: 116·120. 6. Appelbaum PC, Moodley J, Chatterton SA, et al. Tinidazole in the prophylaxis and treatment of anaerobic infection. Chemotherapy 1980; 26: 145·15 I. 7. Saario I, Wuokko E, Saario L, Silvola H. Metronidazole prophylaxis against wound infection in patients undergoing appendicectomy. Ann Chir Gynaecol 1981; 70: 71·74. 8. Hunt PS, Francis JK, Peck C, et al. Tinidazole in the prevention of wound infection after elective colorectal surgery. MedJ Aust 1979; I: 107·109. 9. Willis AT, Ferguson IR, Jones PH, et al. Metronidazole in prevention and treatment of bacteroides infections in elective colonic surgery. Br MedJ 1977; I: 607·610. 10. PalmuA, Renkonen OU, AromaaU. Ornidazole and anaerobic bacteria: in vitro sensitivity and effects on wound infection after appendicectomy. J Infect Dis 1979; 139: 586·589. II. Mclean A, Ioannides-Demos L,Somogyi A,et al.Successful substitution of rectal metronidazole administration for intravenous use. Lancet 1983; I: 41·43. 12. Sutter VL, Finegold SM. Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrob AgentsChemother 1976; 10: 736·752. Il Chow AW, Bendnorz 0, Guze LB. Susceptibility of obligate anaerobes to metronidazole: an extended study of 1,054 clinical isolates. In: Finegold SM,ed. Metronidazole: proceedings of the International Metronidazole Conference. Montreal: Excepta Medica, 1976; 286·292. 14. Haller I. In vitro activity of the two principal oxidative metabolites of metronidazole against Bacteroides fragilis and related species. Antimicrob Agents Chemother 1982; 22: 165·166. 15. Ioannides L, Somogyi A, Spicer J, et al. Rectal administration of metronidazole provides therapeutic plasma levels in postoperative patients. N EnglJ Med 1981; 305: 1569·1570. 16. Coulthard K, Gibson R, Magee H, O'Brien P. Rectal Flagyl for prophylaxis in acute appendicitis (abstract). Aust J Hasp Pharm 1984; 14: 3l 17. FarrellG, Baird-Lambert J, Cvejic M,et al. Impaired elimination of metronidazole in decompensated chronicliverdisease. Br MedJ 1983; 287: 1845. 18. Ludwig E, CsibaA, Magyar T, et al. Age-associated pharmacokinetic changes of metronidazole. Int J Clin Pharmacol Ther Toxico/1983; 21: 87-91. 19. Head PB, Gibson M. Possible alteration of metronidazole metabolism by phenobarbital. N EnglJ Med 1982; 306: 1490. 20. GeorgeWL,KirbyBD,SutterVL,et al. Intravenous metronidazole for treatment of infections involving anaerobic bacteria. Antimicrob AgentsChemother 1982; 21: 441-449. 21. Wheeler LA, De Meo M, Halula M, et al. Use of high pressure liquid chromotography to determine plasma levels of metronidazole and metabolites after intravenous administration. Antimicrob Agents Chemother 1978; 13: 205-209. 22. Somogyi A, KongC, SabtoJ, et al. Disposition and removal of metronidazole in patientsundergoing haemodialysis, EurJ Clin Pharmacol 1983; 25:683-687.